Oral hypoglycemic drugs - Combination therapy with insulin
Kaku, K.
Journal of the Japan Diabetes Society 36(8): 607-611
1993
Accession: 032657567
Full-Text Article emailed within 1 workday
Payments are secure & encrypted
References
Bruni, B.; Albonico, G.; Neirotti, R. 1958: The six-minute test with glucagonfree insulin (Anderson test) and oral therapy of diabetes with synthetic hypoglycemic drugs; notes on the mechanism of action of hypoglycemic drugs Minerva Medica 49(10): 376-380Hirose, T. 2012: Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 669-677
Garber, A.J. 2003: Benefits of combination therapy of insulin and oral hypoglycemic agents Archives of Internal Medicine 163(15): 1781-1782
Vallade, L.; Hugonenq, H.; Jude, J.P. 1957: Experiments in including hypoglycemic comas by a combination of insulin and the oral hypoglycemic sulfonamide BZ 55 Annales Medico-Psychologiques 115(2): 339-343
Mozersky, R.P.; Patel, H.; Bahl, V.K.; Bahl, S.; Mook, W. 1996: Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type Ii diabetes during a 1-year period Journal of the American Osteopathic Association 96(6): 346-351
Quatraro, A.; Consoli, G.; Minei, A.; Pinto, D.; Cataldo, L.; Ceriello, A.; Giuglicano, D. 1991: Stepped combination therapy in obese diabetics treated with insulin following secondary failure of oral hypoglycemic agents Alimentazione Nutrizione Metabolismo 12(2): 135-138
Bruni, B.; Albonico, G.; Neirotti, R. 1958: The six-minute test with glucagon-free insulin (Anderson test) and therapy of diabetes with synthetic hypoglycemic drugs; notes on prognostic criteria of the therapeutic results of hypoglycemic drugs Minerva Medica 49(10): 381-383
Hollander, P.; Sugimoto, D.; Vlajnic, A.; Kilo, C. 2015: Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy Journal of Diabetes and its Complications 29(8): 1266-1271
Mori, Y. 2011: Exploring an optimal approach to the use of oral hypoglycemic agents based on CGM results: implications for combination therapy with oral hypoglycemic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 69(8): 1505-1514
O'brien, S.V.; Mangnall, M.; Mcnulty, S.J.; Hardy, K.J. 1999: Metformin superior to gliclazide when used in combination with NPH insulin in Type 2 diabetic patients inadequately controlled on oral hypoglycemic therapy - Median follow-up 13 months Diabetes 48(Suppl 1): A115-A116
Lechleitner, M.; Roden, M.; Haehling, E.; Mueller, M. 2005: Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional insulin therapy in type 2 diabetes mellitus Wiener Klinische Wochenschrift 117(17): 593-598
Lotz, N.; Bachmann, W. 1993: Combination therapy of oral antidiabetic drugs with insulin Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(3): 130-134
Yoshioka, N. 2009: Progress in therapy for diabetes mellitus--insulin therapy combined with oral hypoglycemic agents( basal supported oral therapy) Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 98(4): 756-760
Tang, Y.-Z.; Wang, G.; Jiang, Z.-H.; Yan, T.-T.; Chen, Y.-J.; Yang, M.; Meng, L.-L.; Zhu, Y.-J.; Li, C.-G.; Li, Z.; Yu, P.; Ni, C.-L. 2015: Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent Diabetology and Metabolic Syndrome 7: 91
Zhou, J.; Zheng, F.; Guo, X.; Yang, H.; Zhang, M.; Tian, H.; Guo, L.; Li, Q.; Mo, Y.; Jia, W. 2015: Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs Diabetes/Metabolism Research and Reviews 31(7): 725-733
Carta, Q.; Trovati, M.; Dani, F.; Caselle, M.T.; Vitali, S.; Cavalot, F.; Rocca, G.; Cantino, G.; Mularoni, E.; Libertucci, D. 1984: Insulin or insulin + oral hypoglycemic drugs in the treatment of type 2 diabetes difficult to compensate metabolically? Minerva Endocrinologica 9(2): 241-245
Kanda, T.; Imano, E.; Matsushima, H.; Wada, M.; Kubota, M.; Yamasaki, Y.; Kamada, T.; Kawamori, R. 1996: The usefulness of combination therapy with preprandial rapid-acting insulin injections and alpha-glucosidase inhibitor in non-obese NIDDM patients with secondary failure on oral hypoglycemic agents Journal of the Japan Diabetes Society 39(3): 183-190
Maiz, A.; Manrique, M.; Arteaga, A.; Acosta, A.M.; Andrade, L. 1995: Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs Revista Medica de Chile 123(10): 1199-1203
Aschner, P.; Kattah, W. 1992: Effects of the combination of insulin and gliclazide compared with insulin alone in type 2 diabetic patients with secondary failure to oral hypoglycemic agents Diabetes Research and Clinical Practice 18(1): 23-30
Stenman, S.; Groop, P.H.; Saloranta, C.; Tötterman, K.J.; Fyhrqvist, F.; Groop, L. 1988: Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents Diabetologia 31(4): 206-213